G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Report 2026
Download Free Sample Buy Now
G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Report Infographic Image

Published : February 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Report 2026

By Therapy Type (Monoclonal Antibodies, Bispecific Antibodies, Chimeric Antigen Receptor (CAR-T) Cell Therapies, Other Therapy Types), By Indication (Multiple Myeloma, Solid Tumors, Other Indications), By Technology (Precision Medicine Approaches, Molecular Targeted Therapy, Cancer Immunotherapy Platforms, Biopharmaceutical Drug Delivery Systems), By Route Of Administration (Intravenous, Subcutaneous, Other Routes Of Administration), By End-User (Hospitals, Specialty Clinics, Research Institutes, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Overview

• G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies market size has reached to $0.59 billion in 2025

• Expected to grow to $2.42 billion in 2030 at a compound annual growth rate (CAGR) of 32.9%

• Growth Driver: Rising Myeloma Prevalence Drives Demand For The Market Due To Growing Patient Burden

• Market Trend: Innovative Immunotherapy Approaches For Relapsed And Refractory Multiple Myeloma

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market?

G protein-coupled receptor family C group 5 member D (GPRC5D) targeted therapies are precision treatments designed to selectively recognize and attack cells expressing the GPRC5D protein, a receptor highly present on malignant plasma cells, especially in multiple myeloma. It helps to provide highly targeted cancer therapy that maximizes tumor elimination while minimizing harm to healthy tissues.

The main types of G protein-coupled receptor family C group 5 member D (GPRC5D) targeted therapies include monoclonal antibodies, bispecific antibodies, chimeric antigen receptor (CAR-T) cell therapies, and other therapy types. Monoclonal antibodies refer to laboratory-produced antibodies designed to specifically target GPRC5D proteins on cancer cells to inhibit tumor growth and stimulate immune response. These therapies are used for indications such as multiple myeloma, solid tumors, and other indications. They use technologies including precision medicine approaches, molecular Targeted Therapy, cancer immunotherapy platforms, and biopharmaceutical drug delivery systems. They are administered via intravenous, subcutaneous, and other routes of administration, and are used by end users including hospitals, specialty clinics, research institutes, and other end users.

G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Report bar graph

What Is The G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Size and Share 2026?

The g protein-coupled receptor family c group 5 member d (gprc5d) targeted therapies market size has grown exponentially in recent years. It will grow from $0.59 billion in 2025 to $0.78 billion in 2026 at a compound annual growth rate (CAGR) of 32.7%. The growth in the historic period can be attributed to advancements in targeted cancer therapy research, increasing prevalence of multiple myeloma cases, expansion of monoclonal antibody development programs, improvements in clinical trial infrastructure, rising investments in oncology drug discovery.

What Is The G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Growth Forecast?

The g protein-coupled receptor family c group 5 member d (gprc5d) targeted therapies market size is expected to see exponential growth in the next few years. It will grow to $2.42 billion in 2030 at a compound annual growth rate (CAGR) of 32.9%. The growth in the forecast period can be attributed to increasing regulatory approvals for targeted biologics, rising demand for personalized cancer treatments, expansion of next-generation immunotherapy platforms, growing investments in precision medicine ecosystems, increasing adoption of biomarker-based therapy selection. Major trends in the forecast period include increasing development of bispecific antibody therapies, rising focus on gprc5d biomarker-driven patient selection, growing adoption of car-t cell platforms, expansion of precision oncology clinical pipelines, enhanced integration of companion diagnostics.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Segmentation

1) By Therapy Type: Monoclonal Antibodies; Bispecific Antibodies; Chimeric Antigen Receptor (CAR-T) Cell Therapies; Other Therapy Types

2) By Indication: Multiple Myeloma; Solid Tumors; Other Indications

3) By Technology: Precision Medicine Approaches; Molecular Targeted Therapy; Cancer Immunotherapy Platforms; Biopharmaceutical Drug Delivery Systems

4) By Route Of Administration: Intravenous; Subcutaneous; Other Routes Of Administration

5) By End-User: Hospitals; Specialty Clinics; Research Institutes; Other End-Users

Subsegments:

1) By Monoclonal Antibodies: Fully Human Monoclonal Antibodies; Humanized Monoclonal Antibodies; Chimeric Monoclonal Antibodies; Murine Monoclonal Antibodies

2) By Bispecific Antibodies: Dual Targeting Bispecific Antibodies; Cross Linking Bispecific Antibodies; Immune Cell Engaging Bispecific Antibodies; Cytotoxic Bispecific Antibodies

3) By Chimeric Antigen Receptor (CAR-T) Cell Therapies: Autologous Car T Cell Therapies; Allogeneic Car T Cell Therapies; Next Generation Car T Cell Therapies; Gene Edited Car T Cell Therapies

4) By Other Therapy Types: Targeted Small Molecule Drugs; Receptor Specific Inhibitors; Injectable Biologics; Oral Targeted Therapeutics

What Is The Driver Of The G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market?

The rising myeloma prevalence is expected to propel the growth of the GPRC5D-targeted therapies market going forward. Myeloma is a cancer of plasma cells in the bone marrow that disrupts normal blood cell production and can cause bone damage, anemia, and kidney problems. The incidence of myeloma is increasing partly due to aging populations, because the risk of developing plasma cell disorders rises with age as genetic mutations accumulate over time. GPRC5D-targeted therapies help treat myeloma by binding to the GPRC5D protein on malignant plasma cells and directing the immune system, especially T cells, to selectively kill these cancerous cells, while sparing most normal cells. For instance, in January 2026, according to the American Cancer Society, a US-based professional organization, in 2026, the United States is expected to record approximately 36,000 new cases of multiple myeloma, including 20,150 cases in men and 15,850 cases in women, with around 10,850 deaths anticipated, comprising 5,780 men and 5,070 women. Therefore, the rising myeloma prevalence is driving the growth of the GPRC5D-targeted therapies market.

Key Players In The Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

Major companies operating in the g protein-coupled receptor family c group 5 member d (gprc5d) targeted therapies market are Johnson And Johnson, F. Hoffmann-La Roche AG., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Bristol Myers Squibb Company, Genmab A/S, Genentech Inc., Simcere Zaiming Biotechnology Co. Ltd., Innovent Biologics Inc., Essen Biotech Co. Ltd., Nanjing IASO Biotechnology Co. Ltd., CARsgen Therapeutics Holdings Limited, Oricell Therapeutics Co. Ltd., Integral Molecular Inc., Overland Therapeutics Inc., Qilu Pharmaceutical Co. Ltd., Leads Biolabs Ltd., ShanghAI Yake Biotechnology Co. Ltd., Guangzhou Bio-gene Technology Co. Ltd.

Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Trends and Insights

Major companies operating in the GPRC5D targeted therapies market are focusing on developing innovative solutions, such as bispecific T cell engagers, to enhance immune-mediated targeting of cancer cells and improve treatment efficacy. A bispecific T-cell engager (BiTE) is a type of immunotherapy molecule designed to connect T-cells directly to cancer cells by binding both simultaneously, activating the T-cells to destroy the targeted cancer cells. For instance, in August 2023, Johnson & Johnson, a US-based healthcare company, received an approval from the European Commission of TALVEY (talquetamab), Janssen's bispecific antibody therapy targeting GPRC5D, for relapsed and refractory multiple myeloma (RRMM) in patients after at least three prior therapies. It is a first-in-class bispecific T-cell engager targeting GPRC5D on multiple myeloma cells and CD3 on T cells to treat relapsed/refractory multiple myeloma in heavily pretreated patients. Its key purpose is providing durable responses (ORR >70% in trials) after at least four prior therapies, with advantages including subcutaneous dosing, sustained quality-of-life benefits, and efficacy even post-bispecifics or CAR-T, filling an unmet need in late-line disease.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market?

In May 2023, LaNova Medicines Ltd., a China-based clinical-stage biotechnology company, partnered with AstraZeneca Plc to advance the development of novel oncology therapies through joint clinical programs. Through this partnership, AstraZeneca aims to obtain worldwide rights to research, develop, and commercialize LM-305, a preclinical-stage GPRC5D-targeting antibody-drug conjugate (ADC) for the treatment of relapsed or refractory multiple myeloma. AstraZeneca plc, a UK-based company that develops GPRC5D-targeted therapies for the treatment of multiple myeloma.

Regional Insights

North America was the largest region in the GPRC5D targeted therapies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the g protein-coupled receptor family c group 5 member d (gprc5d) targeted therapies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the g protein-coupled receptor family c group 5 member d (gprc5d) targeted therapies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market?

The G protein-coupled receptor family C group 5 member D (GPRC5D) targeted therapies market consists of revenues earned by entities by providing services such as clinical trial management, personalized therapy design, patient screening and biomarker testing, regulatory consulting, and post-marketing support. The market value includes the value of related goods sold by the service provider or included within the service offering. The G protein-coupled receptor family C group 5 member D (GPRC5D) targeted therapies market also includes sales of monoclonal antibodies, antibody drug conjugates, targeted small molecule drugs, receptor-specific inhibitors, injectable biologics, oral targeted therapeutics, infusion kits, diagnostic companion kits, laboratory reagents, and vials and prefilled syringes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Report 2026?

The g protein-coupled receptor family c group 5 member d (gprc5d) targeted therapies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the g protein-coupled receptor family c group 5 member d (gprc5d) targeted therapies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $0.78 billion
Revenue Forecast In 2035 $2.42 billion
Growth Rate CAGR of 32.7% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Therapy Type, Indication, Technology, Route Of Administration, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Johnson And Johnson, F. Hoffmann-La Roche AG., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Bristol Myers Squibb Company, Genmab A/S, Genentech Inc., Simcere Zaiming Biotechnology Co. Ltd., Innovent Biologics Inc., Essen Biotech Co. Ltd., Nanjing IASO Biotechnology Co. Ltd., CARsgen Therapeutics Holdings Limited, Oricell Therapeutics Co. Ltd., Integral Molecular Inc., Overland Therapeutics Inc., Qilu Pharmaceutical Co. Ltd., Leads Biolabs Ltd., ShanghAI Yake Biotechnology Co. Ltd., Guangzhou Bio-gene Technology Co. Ltd.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data & Cybersecurity

4.1.5 Fintech, Blockchain, Regtech & Digital Finance

4.2. Major Trends

4.2.1 Increasing Development Of Bispecific Antibody Therapies

4.2.2 Rising Focus On Gprc5D Biomarker-Driven Patient Selection

4.2.3 Growing Adoption Of Car-T Cell Platforms

4.2.4 Expansion Of Precision Oncology Clinical Pipelines

4.2.5 Enhanced Integration Of Companion Diagnostics

5. G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Oncology Clinics

5.3 Research Institutes

5.4 Pharmaceutical Companies

5.5 Biotechnology Companies

6. G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Size, Comparisons And Growth Rate Analysis

7.3. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Segmentation

9.1. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monoclonal Antibodies, Bispecific Antibodies, Chimeric Antigen Receptor (CAR-T) Cell Therapies, Other Therapy Types

9.2. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Multiple Myeloma, Solid Tumors, Other Indications

9.3. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Precision Medicine Approaches, Molecular Targeted Therapy, Cancer Immunotherapy Platforms, Biopharmaceutical Drug Delivery Systems

9.4. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Intravenous, Subcutaneous, Other Routes Of Administration

9.5. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Research Institutes, Other End-Users

9.6. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Fully Human Monoclonal Antibodies, Humanized Monoclonal Antibodies, Chimeric Monoclonal Antibodies, Murine Monoclonal Antibodies

9.7. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Sub-Segmentation Of Bispecific Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dual Targeting Bispecific Antibodies, Cross Linking Bispecific Antibodies, Immune Cell Engaging Bispecific Antibodies, Cytotoxic Bispecific Antibodies

9.8. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Sub-Segmentation Of Chimeric Antigen Receptor (CAR-T) Cell Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Autologous Car T Cell Therapies, Allogeneic Car T Cell Therapies, Next Generation Car T Cell Therapies, Gene Edited Car T Cell Therapies

9.9. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Targeted Small Molecule Drugs, Receptor Specific Inhibitors, Injectable Biologics, Oral Targeted Therapeutics

10. G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Regional And Country Analysis

10.1. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

11.1. Asia-Pacific G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

12.1. China G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

13.1. India G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

14.1. Japan G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

15.1. Australia G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

16.1. Indonesia G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

17.1. South Korea G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

18.1. Taiwan G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

19.1. South East Asia G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

20.1. Western Europe G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

21.1. UK G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

22.1. Germany G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

23.1. France G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

24.1. Italy G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

25.1. Spain G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

26.1. Eastern Europe G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

27.1. Russia G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

28.1. North America G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

29.1. USA G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

30.1. Canada G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

31.1. South America G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

32.1. Brazil G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

33.1. Middle East G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

34.1. Africa G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Segmentation By Indication, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Regulatory and Investment Landscape

36. G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Competitive Landscape And Company Profiles

36.1. G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Company Profiles

36.3.1. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F. Hoffmann-La Roche AG. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

37. G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Other Major And Innovative Companies

Bristol Myers Squibb Company, Genmab A/S, Genentech Inc., Simcere Zaiming Biotechnology Co. Ltd., Innovent Biologics Inc., Essen Biotech Co. Ltd., Nanjing IASO Biotechnology Co. Ltd., CARsgen Therapeutics Holdings Limited, Oricell Therapeutics Co. Ltd., Integral Molecular Inc., Overland Therapeutics Inc., Qilu Pharmaceutical Co. Ltd., Leads Biolabs Ltd., Shanghai Yake Biotechnology Co. Ltd., Guangzhou Bio-gene Technology Co. Ltd.

38. Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market

41. G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market High Potential Countries, Segments and Strategies

41.1 G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market In 2030 - Countries Offering Most New Opportunities

41.2 G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market In 2030 - Segments Offering Most New Opportunities

41.3 G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market In 2030 - Growth Strategies

41.3.1 Market Trend Based Strategies

41.3.2 Competitor Strategies

42. Appendix

42.1. Abbreviations

42.2. Currencies

42.3. Historic And Forecast Inflation Rates

42.4. Research Inquiries

42.5. The Business Research Company

42.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Overview Of Key Products - Product Examples
  • Table 2: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Supply Chain Analysis
  • Table 4: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Major Raw Material Providers
  • Table 5: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Major Resource Providers
  • Table 6: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Major Manufacturers (Suppliers)
  • Table 7: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Major Distributors And Channel Partners
  • Table 8: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Key Technologies & Future Trends
  • Table 9: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Major Trends
  • Table 10: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Major End Users
  • Table 11: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market - TAM, US$ Billion, 2025
  • Table 15: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Sub-Segmentation Of Bispecific Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Sub-Segmentation Of Chimeric Antigen Receptor (CAR-T) Cell Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia , G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia , G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia , G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 99: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market - Company Scoring Matrix
  • Table 100: Upcoming Startups
  • Table 101: Johnson And Johnson Financial Performance
  • Table 102: F. Hoffmann-La Roche AG. Financial Performance
  • Table 103: AbbVie Inc. Financial Performance
  • Table 104: Sanofi S.A. Financial Performance
  • Table 105: AstraZeneca plc Financial Performance
  • Table 106: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Competitive Benchmarking (In USD Billions)
  • Table 107: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Competitive Dashboard
  • Table 108: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 109: Global, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030
  • Table 110: Global, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Table 111: Global, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

List Of Figures

    Figure 1: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Overview Of Key Products - Product Examples
  • Figure 2: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Supply Chain Analysis
  • Figure 4: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Major Raw Material Providers
  • Figure 5: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Major Resource Providers
  • Figure 6: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Major Manufacturers (Suppliers)
  • Figure 7: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Major Distributors And Channel Partners
  • Figure 8: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Key Technologies & Future Trends
  • Figure 9: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Major Trends
  • Figure 10: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Major End Users
  • Figure 11: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market - TAM, US$ Billion, 2025
  • Figure 15: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Sub-Segmentation Of Bispecific Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Sub-Segmentation Of Chimeric Antigen Receptor (CAR-T) Cell Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Sub-Segmentation Of Other Therapy Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia , G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia , G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia , G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Therapy Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 99: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market - Company Scoring Matrix
  • Figure 100: Upcoming Startups
  • Figure 101: Johnson And Johnson Financial Performance
  • Figure 102: F. Hoffmann-La Roche AG. Financial Performance
  • Figure 103: AbbVie Inc. Financial Performance
  • Figure 104: Sanofi S.A. Financial Performance
  • Figure 105: AstraZeneca plc Financial Performance
  • Figure 106: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Competitive Benchmarking (In USD Billions)
  • Figure 107: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market, Competitive Dashboard
  • Figure 108: Global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 109: Global, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Size Gain ($ Billion), Segmentation By Therapy Type, 2025 – 2030
  • Figure 110: Global, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030
  • Figure 111: Global, G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

G-Protein Coupled Receptors Market Report 2026 - Global Outlook – By Product (Cell Lines, Detection Kits, Cell Culture Reagents, Ligands), By Assay (CAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functiona...

CC Chemokine Receptor Type 5 Market Report 2026 - Global Outlook – By Type (BMS-813160, AG-1105, DS-001, Other Types), By Distribution Channel (Hospitals, Clinics), By Application (Infectious Disease, Immunology, Oncolog...

GMP Cell Therapy Consumables Market Report 2026 - Global Outlook – By Product (Kits, Reagents Or Molecular Biology Reagents, Growth Factors Or Cytokines And Interleukins, Other Products), By Cell Therapy (NK Cell Therapy...

Glycomic Therapeutics Market Report 2026 - Global Outlook – By Class (Isolated, Synthetic), By Structures (Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (...

Glucagon-like Peptide 1 Market Report 2026 - Global Outlook – By Product (Trulicity, Ozempic, Victoza, Rybelsus, Other Types), By Route of Administration (Oral, Parenteral, Other Routes), By End-Users (Hospitals, Special...

C-X-C Chemokine Receptor 4 (CXCR4) Antagonists Market Report 2026 - Global Outlook – By Type (BL-8040, GMI-1359, Plerixafor (AMD3100), Balixafortide (POL6326), USL311, Burixafor (GPC-100), Other Types), By Route Of Admin...

Vitamin D Therapy Market Report 2026 - Global Outlook – By Administration (Oral, Parenteral), By Purchasing (OTC Drugs, Prescription Drugs), By Age Group (Children, Adults, Senior Adults), By Application (Osteoporosis, R...

Peptide Therapeutics Market Report 2026 - Global Outlook – By Type (Generic, Branded), By Route of Administration (Parenteral, Mucosal, Oral, Transdermal), By Application (Cancer, Cardiovascular Diseases, Central Nervous...

Frequently Asked Questions

The G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies market was valued at $0.59 billion in 2025, increased to $0.78 billion in 2026, and is projected to reach $2.42 billion by 2030.

The global G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies market is expected to grow at a CAGR of 32.9% from 2026 to 2035 to reach $2.42 billion by 2035.

Some Key Players in the G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) Targeted Therapies market Include, Johnson And Johnson, F. Hoffmann-La Roche AG., AbbVie Inc., Sanofi S.A., AstraZeneca plc, Bristol Myers Squibb Company, Genmab A/S, Genentech Inc., Simcere Zaiming Biotechnology Co. Ltd., Innovent Biologics Inc., Essen Biotech Co. Ltd., Nanjing IASO Biotechnology Co. Ltd., CARsgen Therapeutics Holdings Limited, Oricell Therapeutics Co. Ltd., Integral Molecular Inc., Overland Therapeutics Inc., Qilu Pharmaceutical Co. Ltd., Leads Biolabs Ltd., ShanghAI Yake Biotechnology Co. Ltd., Guangzhou Bio-gene Technology Co. Ltd. .

Major trend in this market includes: Innovative Immunotherapy Approaches For Relapsed And Refractory Multiple Myeloma. For further insights on this market. request a sample here

North America was the largest region in the GPRC5D targeted therapies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the g protein-coupled receptor family c group 5 member d (gprc5d) targeted therapies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us